47 results on '"Ghaneh P"'
Search Results
2. Drainage and Bypass Procedures for Palliation of Malignant Diseases of the Upper Gastrointestinal Tract
3. When Is Pancreatitis Considered to Be of Biliary Origin and What Are the Implications for Management?
4. Early and late complications after pancreatic necrosectomy
5. Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial
6. The Effect of Sampling Methodology upon Pancreatic Cancer Microbiome Communities
7. Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
8. Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis
9. Diagnosis, treatment and outcome of pancreatoblastoma
10. Hereditary pancreatic endocrine tumours
11. P-85 Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK)
12. Adjuvant therapy in pancreatic cancer: historical and current perspectives
13. Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study
14. Prognostic impact of CA 19-9 levels in patients with resectable pancreatic cancer who receive adjuvant chemotherapy in randomized controlled trials: A systematic review
15. The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer
16. GATA4 and GATA6 cooperate to drive tumor biology and patient outcome in human PDAC
17. Gene therapy for pancreatic cancer—current and prospective strategies
18. The future of surgery for pancreatic cancer
19. PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy – a randomised double blind multi-centre trial: Final trial results.
20. ESPAC-5F: Four arm, international randomised phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer
21. UK Early Detection Initiative (UK-EDI) for Pancreatic Cancer
22. Prevalence of diabetes mellitus among individuals undergoing pancreatic surgery
23. Diagnostic accuracy of 18 FDG PET/CT in the evaluation of suspicious pancreatic cysts
24. Value of 18 FDG PET/CT volumetric parameters in the survival prediction of patients with pancreatic cancer
25. Does tumour SUVmax predict adverse prognostic features in patients with pancreatic cancer?
26. 18FDG PET/CT improves staging of small ≤2 cm pancreatic tumours
27. PMD94 - Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer: An Economic Evaluation Of The PET-PANC Cohort Study
28. ESPAC-4: A multicenter, international, open label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma
29. Pre-operative liver enzyme predicts survival and recurrence after liver resection for hepatocellular carcinoma arising from non-cirrhotic/non-fibrotic liver: A European perspective
30. Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable
31. Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer
32. Ribonucleotide reductase subunit M2 levels affect resistance to gemcitabine in vitro
33. High hENT1 expression is predictive of response of to adjuvant gemcitabine for pancreatic ductal adenocarcinoma patients randomized to adjuvant therapies in the ESPAC trials
34. Detection of mutations in pancreatic juice collected from the duodenum by post secretin-aspiration is not reliable
35. Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer
36. Pancreatic stents with diclofenac reduce the incidence of post ERCP pancreatitis in patients undergoing molecular screening of pancreatic juice for pancreatic cancer
37. Acquired gemcitabine resistance is associated with expression of ribonucleotide reductase subunit M2
38. Pancreatic hamartoma
39. Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma
40. Impact of service centralisation on outcomes for patients with pancreatic cancer
41. Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma
42. PRE-clinical investigation of AT7519, a novel CDK inhibitor, as a potential therapeutic agent in pancreatic cancer
43. Pre-clinical assessment of AT13387, an HSP90 inhibitor, in a pancreatic cancer xenograft model
44. 6151 POSTER Follow up After Hepatectomy for Colorectal Liver Metastases – a Systematic Review and Meta-analysis
45. 2502 POSTER Microwave Ablation of Ex Vivo Human Liver and Colorectal Liver Metastases With a Novel 14.5 GHz Generator
46. Impact of concomitant vascular injuries, speciality of surgeon performing the repair, and subsequent patient psychological concerns in the management of iatrogenic bile duct injuries
47. Le taux sérique de CA 19.9 préthérapeutique permet de sélectionner les patients candidats à une laparoscopie exploratrice visant à évaluer la résécabilité des cancers pancréatiques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.